1. Koch J, Mayr JA, Alhaddad B, Rauscher C, Bierau J, Kovacs-Nagy R, Coene KL, Bader I, Holzhacker M, Prokisch H, Venselaar H, Wevers RA, Distelmaier F, Polster T, Leiz S, Betzler C, Strom TM, Sperl W, Meitinger T, Wortmann SB, Haack TB. CAD mutations and uridine-responsive epileptic encephalopathy. Brain. 2017;140(Pt 2):279–86. https://doi.org/10.1093/brain/aww300 .
2. Carvalho, M. Extemporaneously Compounded Oral Medicines in European Hospital Pharmacies. Doctoral thesis, UCL (University College London); 2013.
3. Aprofarm, IX Symposium: Unification of criteria for paediatric formulations – Programme leaflet. Available at: http://www.formulistasdeandalucia.es/ficheros/9472%20triptico%20Pediatria.pdf Accessed: 21 May 2017.
4. European Parliament and the Council. Directive 2001/83/EC of 6 November on the community code relating to medicinal products for human use. Off J Eur Communities. 2001;L311:67–128.
5. European Parliament and the Council. Directive 2004/27/EC of 31 march amending directive 2001/83/EC on the community code relating to medicinal products for human use. Off J Eur Union. 2004;L136:34–57.